Throughout clinical trials, we employ spirometry to monitor lung and bronchial function, echocardiography to assess the structure and functions of the heart and lungs, bronchoscopy to biopsy the respiratory tract, and a pulse oximeter to measure blood oxygen saturation.
The medications we researched for treating bronchial asthma and COPD demonstrated impressive results, including anti-inflammatory properties, a substantial decrease in the risk of exacerbations, and significant improvement in lung function across patients with varying degrees of disease severity.
ClinicalTrialsUA ensures a comprehensive approach to clinical trials in any of the 18 available therapeutic areas.
Our services encompass:
- Tailored and personalized approach
- Utilizing cutting-edge technologies
- Partnering with top specialists
- A solid scientific perspective on research outcomes
- The largest pool of patients for research participation
Respiratory tract chronic diseases rank third in terms of mortality among all diseases.
These conditions impact approximately 550 million people globally, with a majority experiencing asthma and chronic obstructive pulmonary disease (COPD).
Although asthma and COPD differ in causes and symptoms, they share a common feature—a concealed and substantial level of chronic inflammation in the respiratory tract.
To enhance the likelihood of therapeutic success, it is essential to tailor treatments to individual patients. This underscores the importance of clinical trials for testing new medications.
High-quality clinical trials play a crucial role in uncovering innovative treatments and enhancing the lives of millions of individuals living with or affected by chronic respiratory diseases.
